Prescription-Only Domperidone: New MHRA Rules to Enhance Patient Safety
In a significant safety measure, the MHRA has mandated that Domperidone, a drug commonly used for treating nausea and vomiting, will require a prescription starting September 4th, 2014. This decision, stimulated by concerns over cardiovascular risks, underscores the importance of medical oversight in medication dispensing.
Teriflunomide and Advocacy: Raising Awareness and Fighting for MS Research Funding
On my journey to raise awareness about Multiple Sclerosis (MS), I've found that Teriflunomide, a drug used for its treatment, plays a significant role. It's been a crucial tool in the fight against this debilitating disease, but there's still a lot we don't know about MS. That's why advocacy for more research funding is so important. We need to ensure scientists have the necessary resources to uncover more about this disease and how to combat it. Together, with continuous advocacy and increased funding, we can look forward to better treatments and, hopefully, a cure for MS.